102 related articles for article (PubMed ID: 11450890)
1. In vitro activity of vinorelbine on human leukemia cells.
Landini I; Bartolozzi B; Banchelli I; Degli Innocenti A; Nocentini O; Bernabei PA
J Chemother; 2001 Jun; 13(3):309-15. PubMed ID: 11450890
[TBL] [Abstract][Full Text] [Related]
2. Activity of vinorelbine on B-chronic lymphocytic leukemia cells in vitro.
Bernabei PA; Landini I; Bartolozzi B; Banchelli I; Degli Innocenti o Nocentini A; Santini V; Ematologia UO
Adv Exp Med Biol; 1999; 457():473-6. PubMed ID: 10500824
[TBL] [Abstract][Full Text] [Related]
3. Vinorelbine-based salvage chemotherapy for therapy-refractory aggressive leukaemias.
Uckun FM; Morar S; Qazi S
Br J Haematol; 2006 Nov; 135(4):500-8. PubMed ID: 17061978
[TBL] [Abstract][Full Text] [Related]
4. [Properties of antitumor activity of vinorelbine tartrate, a new vinca alkaloid antitumor agent].
Kanazawa J; Morimoto M; Ohmori K
Nihon Yakurigaku Zasshi; 2000 Oct; 116(4):215-23. PubMed ID: 11084918
[TBL] [Abstract][Full Text] [Related]
5. Exposure to vinorelbine inhibits in vitro proliferation and invasiveness of transitional cell bladder carcinoma.
Bonfil RD; Russo DM; Schmilovich AJ
J Urol; 1996 Aug; 156(2 Pt 1):517-21. PubMed ID: 8683728
[TBL] [Abstract][Full Text] [Related]
6. Effect of Vinorelbine on cell growth and apoptosis induction in human osteosarcoma in vitro.
Roncuzzi L; Marti G; Baiocchi D; Del Coco R; Cocchi S; Gasperi-Campani A
Oncol Rep; 2006 Jan; 15(1):73-7. PubMed ID: 16328036
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol protects against vinorelbine-induced vascular endothelial cell injury.
Zhang J; Tong N; Chen Y; Li P; Yang S; Zhao X
Toxicol Mech Methods; 2013 Nov; 23(9):665-71. PubMed ID: 23977833
[TBL] [Abstract][Full Text] [Related]
8. Synergistic interaction between vinorelbine and gamma-linolenic acid in breast cancer cells.
Menéndez JA; Ropero S; del Barbacid MM; Montero S; Solanas M; Escrich E; Cortés-Funes H; Colomer R
Breast Cancer Res Treat; 2002 Apr; 72(3):203-19. PubMed ID: 12058962
[TBL] [Abstract][Full Text] [Related]
9. In vitro cytotoxicity of docetaxel in childhood acute leukemias.
Consolini R; Pui CH; Behm FG; Raimondi SC; Campana D
J Clin Oncol; 1998 Mar; 16(3):907-13. PubMed ID: 9508172
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and evaluation of the cytotoxic activity of 1,2-furanonaphthoquinones tethered to 1,2,3-1H-triazoles in myeloid and lymphoid leukemia cell lines.
Cardoso MF; Rodrigues PC; Oliveira ME; Gama IL; da Silva IM; Santos IO; Rocha DR; Pinho RT; Ferreira VF; de Souza MC; da Silva Fde C; Silva FP
Eur J Med Chem; 2014 Sep; 84():708-17. PubMed ID: 25064348
[TBL] [Abstract][Full Text] [Related]
11. Effects of genistein on the growth and cell cycle progression of normal human lymphocytes and human leukemic MOLT-4 and HL-60 cells.
Traganos F; Ardelt B; Halko N; Bruno S; Darzynkiewicz Z
Cancer Res; 1992 Nov; 52(22):6200-8. PubMed ID: 1330289
[TBL] [Abstract][Full Text] [Related]
12. In vitro evaluation of new anticancer drugs, exemplified by vinorelbine, using the fluorometric microculture cytotoxicity assay on human tumor cell lines and patient biopsy cells.
Fridborg H; Nygren P; Dhar S; Csoka K; Kristensen J; Larsson R
J Exp Ther Oncol; 1996 Sep; 1(5):286-95. PubMed ID: 9414416
[TBL] [Abstract][Full Text] [Related]
13. Aspirin attenuates vinorelbine-induced endothelial inflammation via modulating SIRT1/AMPK axis.
Tsai KL; Huang PH; Kao CL; Leu HB; Cheng YH; Liao YW; Yang YP; Chien Y; Wang CY; Hsiao CY; Chiou SH; Chen JW; Lin SJ
Biochem Pharmacol; 2014 Mar; 88(2):189-200. PubMed ID: 24345330
[TBL] [Abstract][Full Text] [Related]
14. [A randomized controlled study on vindesine and vincristine in combination with prednisolone in the treatment of adult acute lymphocytic leukemia and blastic crisis of chronic myeloid leukemia].
Gan To Kagaku Ryoho; 1983 Dec; 10(12):2500-8. PubMed ID: 6580840
[TBL] [Abstract][Full Text] [Related]
15. Vindesine effect in myeloid leukemia.
Baccarani M; Zaccaria A; Corbelli G; Tura S
Cancer Chemother Pharmacol; 1982; 8(3):255-9. PubMed ID: 6957273
[TBL] [Abstract][Full Text] [Related]
16. [Continuous 5-day vindesine in the treatment of leukemias and lymphomas (author's transl)].
Maraninchi D; Gastaut JA; Tubiana N; Carcassonne Y
Bull Cancer; 1981; 68(4):338-42. PubMed ID: 6947833
[TBL] [Abstract][Full Text] [Related]
17. Biochemical pharmacology and resistance to 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine, a novel analogue of cladribine in human leukemic cells.
Lotfi K; Månsson E; Spasokoukotskaja T; Pettersson B; Liliemark J; Peterson C; Eriksson S; Albertioni F
Clin Cancer Res; 1999 Sep; 5(9):2438-44. PubMed ID: 10499616
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of vinorelbine in the cancer therapy.
Galano G; Caputo M; Tecce MF; Capasso A
Curr Drug Saf; 2011 Jul; 6(3):185-93. PubMed ID: 22122393
[TBL] [Abstract][Full Text] [Related]
19. [Therapy of the blast crisis in chronic myeloid leukemia. Results of a phase II study with vindesine].
Hellriegel KP
Folia Haematol Int Mag Klin Morphol Blutforsch; 1981; 108(5):699-706. PubMed ID: 6172337
[No Abstract] [Full Text] [Related]
20. Antitumor activity of troxacitabine (Troxatyl) against anthracycline-resistant human xenografts.
Gourdeau H; Genne P; Kadhim S; Bibeau L; Duchamp O; Ouellet F; deMuys JM; Bouffard DY; Attardo G
Cancer Chemother Pharmacol; 2002 Dec; 50(6):490-6. PubMed ID: 12451476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
